travoprost intraocular implant (Pending FDA Approval)

Brand and Other Names:iDose TR
Sections

Dosing & Uses

Open-angle Glaucoma

Pending FDA approval for reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension

Next:

Pharmacology

Mechanism of Action

Prostaglandin F2-alpha analog; decreases intraocular pressure by increasing outflow of aqueous humor through the trabecular meshwork

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.